What is chronic physical urticaria, specifically dermatographic urticaria (dermographism)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Chronic physical urticaria, specifically dermographism, is a condition characterized by the appearance of raised, red welts in response to physical stimuli, such as firm stroking or scratching of the skin, and is classified as a type of physical urticaria that can be reproducibly induced by the same physical stimulus 1.

Key Characteristics

  • The condition is triggered by mechanical stimuli, resulting in the release of histamine and other inflammatory chemicals from mast cells in the skin 1.
  • The welts typically appear within minutes of skin pressure and may be itchy or painful, usually resolving within 30 minutes to a few hours 1.
  • Dermographism is a type of physical urticaria that is distinct from other forms, such as delayed pressure urticaria, vibratory angio-oedema, and thermal urticarias 1.

Treatment and Management

  • Treatment primarily involves antihistamines, with second-generation options like cetirizine (10mg daily), loratadine (10mg daily), or fexofenadine (180mg daily) being first-line choices due to their minimal sedating effects 1.
  • For more severe cases, higher antihistamine doses or combinations may be needed, and some patients benefit from adding H2 blockers like ranitidine.
  • Avoiding tight clothing, harsh soaps, and extreme temperatures can help reduce flare-ups.
  • Most patients experience significant improvement with consistent antihistamine use, though the condition may persist for years or even decades.
  • If standard treatments fail, dermatology referral may be necessary for consideration of immunomodulatory medications like omalizumab or cyclosporine in severe cases.

Important Considerations

  • The duration of individual weals can be helpful in distinguishing between different clinical patterns, with weals in physical urticaria typically lasting less than an hour 1.
  • Angio-oedema without weals should be distinguished from angio-oedema occurring with weals, as it may be caused by angiotensin-converting enzyme (ACE) inhibitors or be a presentation of C1 esterase inhibitor (C1 inh) deficiency 1.

From the Research

Definition and Characteristics of Chronic Physical Urticaria (Dermographism)

  • Chronic physical urticaria, also known as dermographism, is a common subtype of chronic urticaria that manifests as a linear wheal after scratching or friction, with or without angioedema 2.
  • The condition is characterized by intensely pruritic wheals, sometimes with edema of the subcutaneous or interstitial tissue, and is caused by immunoglobulin E- and non-immunoglobulin E-mediated release of histamine and other inflammatory mediators from mast cells and basophils 3.
  • Dermographism is present in a large number of healthy individuals and is due to a combination of pressure and shearing forces 4.

Diagnosis and Evaluation

  • The gold standard for diagnosis is a medical history and provocation test or dermatographic test 2.
  • The Urticaria Control Test (UCT), Chronic Urticaria Quality of Life questionnaire (CU-Q2oL), and Dermatology Life Quality Index (DLQI) are also effective tools for evaluating disease control in dermographism patients 2.
  • Diagnosis is made clinically, and anaphylaxis must be ruled out 3.

Treatment and Management

  • The mainstay of treatment is avoidance of triggers, if identified 3.
  • Nonsedating H1 antihistamines are the first-line medications recommended for dermographism, and the dosage can be increased up to 4 times for those who do not respond to standard doses 2.
  • Cetirizine, a second-generation antihistamine, has been shown to be effective in reducing symptoms and wealing in dermographic urticaria 5, 6.
  • Omalizumab can be considered for off-label use in refractory cases, and other drugs with potential therapeutic effects are still being explored 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Shedding light on dermographism: a narrative review.

International journal of dermatology, 2024

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Research

Dermographism: a review.

Journal of the American Academy of Dermatology, 1984

Research

Use of cetirizine in dermatologic disorders.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.